James Lillie

James Lillie

Chief Tech/Sci/R&D Officer at MAPLIGHT THERAPEUTICS, INC.

Net worth: 2 M $ as of 29/09/2026

70 year
Health Technology
Consumer Services

Profile

James Lillie is Chief Scientific Officer at MapLight Therapeutics, Inc. since 2019.
Formerly, Dr. Lillie was Senior Director-Biology at Scriptgen Pharmaceuticals, Inc. and Chief Scientific Officer at OvaScience, Inc. in 2018.
Dr. Lillie earned a doctorate from Harvard University and completed undergraduate studies at Wesleyan University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
14/10/2026 198,597 ( 0.38% ) 2 M $ 29/09/2026

James Lillie active positions

CompaniesPositionStart
MAPLIGHT THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 31/01/2019

Former positions of James Lillie

CompaniesPositionEnd
Chief Tech/Sci/R&D Officer 06/12/2018
Corporate Officer/Principal -
See the detail of James Lillie's experience

Education of James Lillie

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

18

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies5

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology